On May 18, 2023, the Federal Trade Commission (“FTC”) announced a notice of proposed rulemaking (the “proposed rule”) to “strengthen and modernize” the Health Breach Notification Rule (“HBNR”).  The proposed rule builds on the FTC’s September 2021 “Statement of the Commission on Breaches by Health Apps and Other Connected Devices” (“Policy Statement”), which took a broad approach to when health apps and connected devices are covered by the HBNR and when there is a “breach” for purposes of the HBNR.  The proposed rule primarily would (i) amend many definitions that are central to the scope of the HBNR (e.g., “breach of security,” “health care provider,” and “personal health record”), and (ii) authorize expanded means for providing notice to consumers of a breach and require additional notice content.  According to the FTC, these changes to the HBNR would ensure the HBNR “remains relevant in the face of changing business practices and technological developments.”  Below, we provide a brief summary of the history of the HBNR leading up to this proposed rule, a brief summary of the proposed rule, and a timeline for commenting.

Brief Background

The HBNR was promulgated in 2009 under the HITECH Act.  Under the HBNR, vendors of personal health records that are not otherwise regulated under HIPAA are required to notify individuals, the FTC, and, in some cases, the media following a breach involving unsecured identifiable health information.  When the HNBR was first promulgated, the term “breach” was understood to encompass traditional cybersecurity incidents, such as the hack of system by a bad actor or the loss of company equipment containing identifiable health information.  Third-party service providers also are required to notify covered vendors of a breach.  (As background, “unsecured” health information is information that is not secured through technologies or methodologies specified by the Department of Health and Human Services, primarily encryption for electronic information.)  

In 2021, the Policy Statement adopted a significantly broader interpretation of the HBNR.  Specifically, the Policy Statement specified that (1) a developer of any digital health solution that is “capable of drawing information from multiple inputs” is a vendor of a personal health records subject to the HBNR, and (2) the developer of a health app or connected device is a “health care provider” because it “furnish[es] health care services or supplies.”  Additionally, the Policy Statement specified that a “breach” for purposes of the HBNR is triggered not only by a cybersecurity incident, but also when “a health app, for example, discloses sensitive health information without users’ authorization.”

Since the issuance of the Policy Statement, the FTC has brought its first two enforcement actions under the HBNR, leveraging its broad interpretation of the meaning of “breach.”  For more information, see our blog posts on the GoodRx and Easy Healthcare enforcement actions. 

Key Provisions

  • Updated Definitions: The proposed rule would amend existing definitions and create new definitions to “clarify that that mobile health applications are covered by the” HBNR and expand the types of events that trigger notice requirements.  Some takeaways include:
    • A revised “personal health records identifiable information” definition that the FTC believes will cover traditional health information, health information derived from consumers’ interactions with apps and other online services (i.e., health information generated from tracking technologies on websites or apps), and emergent health data (i.e., health information inferred from non-health-related data, such as location and recent purchases).A new “health care provider” definition that includes a provider of medical or other health services, or any other entity furnishing “health care services or supplies” (i.e., websites, apps, and Internet-connected devices that provide mechanisms to track health conditions, medications, fitness, sleep, etc.).A revised “personal health record related entity” definition that, among other things, specifies that only entities that access or send unsecured personal health record identifiable health information (rather than entities that access or send any information) to a personal health record qualify as a “personal health record related entity.”  Examples of devices that could qualify as a personal health record related entity include “[r]emote blood pressure cuffs, connected blood glucose monitors, and fitness trackers . . . when individuals synch [the device] with a personal health record (i.e., mobile health application).”A revised “personal health record” definition that adopts the Policy Statement’s view that a product is a personal health record if it “has the technical capacity to draw information” from multiples sources.  This means that an app constitutes a personal health record, for example, if it has the capacity to accept user input and sync with a wearable sleep monitor.  The revised definition clarifies that the app will still be a personal health record even if the user never actually syncs the app with the sleep monitor.  It also clarifies that an app is still a personal health record if it can draw any information from multiple sources, even if it receives health information from only one source.
    • A modified “breach of security” definition, building on the Policy Statement and recent enforcement actions, which clarifies that the HBNR covers not only cybersecurity incidents, but also includes unauthorized disclosures of consumer health information to third parties.
  • Method of Notice and Content: The proposed rule would allow vendors of personal health records that discover a breach to provide written notice via electronic email if the consumer has specified electronic email as the primary contact method.  The FTC would require, however, that a notification sent via email be sent in combination with a text message, within-application message, or electronic banner.  In addition, the FTC’s proposal would modify the content of the required notice to, among other things, require information about the potential harm stemming from the breach and the names of any third parties who might have acquired unsecured personally identifiable health information.  The FTC has developed and provided a model notice.

Comment Period

Stakeholders interested in commenting on the proposed rule will have 60 days from the date that the notice is published in the Federal Register.  As of the date of this blog post, the notice has not yet been posted.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Libbie Canter Libbie Canter

Libbie Canter represents a wide variety of multinational companies on privacy, cyber security, and technology transaction issues, including helping clients with their most complex privacy challenges and the development of governance frameworks and processes to comply with global privacy laws. She routinely supports…

Libbie Canter represents a wide variety of multinational companies on privacy, cyber security, and technology transaction issues, including helping clients with their most complex privacy challenges and the development of governance frameworks and processes to comply with global privacy laws. She routinely supports clients on their efforts to launch new products and services involving emerging technologies, and she has assisted dozens of clients with their efforts to prepare for and comply with federal and state privacy laws, including the California Consumer Privacy Act and California Privacy Rights Act.

Libbie represents clients across industries, but she also has deep expertise in advising clients in highly-regulated sectors, including financial services and digital health companies. She counsels these companies — and their technology and advertising partners — on how to address legacy regulatory issues and the cutting edge issues that have emerged with industry innovations and data collaborations.

As part of her practice, she also regularly represents clients in strategic transactions involving personal data and cybersecurity risk. She advises companies from all sectors on compliance with laws governing the handling of health-related data. Libbie is recognized as an Up and Coming lawyer in Chambers USA, Privacy & Data Security: Healthcare. Chambers USA notes, Libbie is “incredibly sharp and really thorough. She can do the nitty-gritty, in-the-weeds legal work incredibly well but she also can think of a bigger-picture business context and help to think through practical solutions.”

Photo of Anna D. Kraus Anna D. Kraus

Anna Durand Kraus advises on issues relating to the complex array of laws governing the health care industry. Her background as Deputy General Counsel to the U.S. Department of Health and Human Services (“HHS”) gives her broad experience with, and valuable insight into…

Anna Durand Kraus advises on issues relating to the complex array of laws governing the health care industry. Her background as Deputy General Counsel to the U.S. Department of Health and Human Services (“HHS”) gives her broad experience with, and valuable insight into, the programs and issues within the purview of HHS, including Medicare, Medicaid, fraud and abuse, and HIPAA privacy and security. Anna is co-chair of the firm’s Health Care Industry practice group.

Anna regularly advises clients on Medicare reimbursement matters, particularly those arising under Part B and the Part D prescription drug benefit. She also has extensive experience with the Medicaid Drug Rebate program. She assists numerous pharmaceutical and device manufacturers, health care providers, pharmacy benefit managers, and other health care industry stakeholders to navigate the challenges and opportunities presented by the Affordable Care Act.

Anna is a trusted adviser on health information privacy, security and breach notification issues, including those arising under the Health Insurance Portability and Accountability Act (“HIPAA”) and the Health Information Technology for Economic and Clinical Health (“HITECH”) Act. Her background in this area dates back to the issuance of the original HIPAA privacy regulations.

Anna’s clients depend on her to guide them through compliance with the Anti-Kickback statute, the Stark regulations, and other laws preventing fraud and abuse in the health care industry. Her deep knowledge of these laws has made her an important component of the firm’s representation of pharmaceutical companies and health care organizations under federal investigation or facing allegations under the False Claims Act. In addition, clients contemplating acquisitions in the health care sector rely on her to guide due diligence efforts.

Photo of Elizabeth Brim Elizabeth Brim

Elizabeth Brim is an associate in the firm’s Washington, DC office, where she is a member of the Data Privacy and Cybersecurity and Health Care Practice Groups and advises clients on a broad range of regulatory and compliance issues related to privacy and…

Elizabeth Brim is an associate in the firm’s Washington, DC office, where she is a member of the Data Privacy and Cybersecurity and Health Care Practice Groups and advises clients on a broad range of regulatory and compliance issues related to privacy and health care.

Elizabeth’s practice includes counseling clients on compliance with the complex web of health information privacy laws and regulations, such as HIPAA, the FTC’s Health Breach Notification Rule, and state medical and consumer health privacy laws as well as state consumer privacy and genetic privacy laws. She also advises clients on health care compliance issues, such as fraud and abuse, market access, and pricing and reimbursement activities.

Elizabeth routinely advises on regulatory compliance as part of transactions, clinical trial programs, collaborations and other activities that involve genetic data, and the development and operation of digital health products. As part of her practice, Elizabeth routinely counsels clients on drafting and negotiating privacy and health care terms with vendors and third parties and developing privacy notices and consent forms. In addition, Elizabeth maintains an active pro bono practice.

Elizabeth is an author of the American Health Law Association treatise, Pricing, Market Access, and Reimbursement Principles: Drugs, Biologicals and Medical Devices and the U.S. chapter of the Global Legal Insights treatise, Pricing & Reimbursement Laws and Regulations.

Photo of Ariel Dukes Ariel Dukes

Ariel Dukes is an associate in the firm’s Washington, DC office and a member of the Data Privacy and Cybersecurity Practice Group.

Ariel counsels clients on data privacy, cybersecurity, and artificial intelligence. Her practice includes partnering with clients on compliance with comprehensive privacy…

Ariel Dukes is an associate in the firm’s Washington, DC office and a member of the Data Privacy and Cybersecurity Practice Group.

Ariel counsels clients on data privacy, cybersecurity, and artificial intelligence. Her practice includes partnering with clients on compliance with comprehensive privacy laws, FTC and consumer protection laws and guidance, and laws governing the handling of health-related data. Additionally, Ariel routinely counsels clients on drafting and negotiating privacy terms with vendors and third parties, developing privacy notices and consent forms, and responding to regulatory inquiries regarding privacy and cybersecurity topics. Ariel also advises clients on trends in artificial intelligence regulations and helps design governance programs for the development and deployment of artificial intelligence technologies across a number of industries.

Photo of Olivia Vega Olivia Vega

Olivia Vega provides strategic advice to global companies on a broad range of privacy, health care, and technology issues, including in technology transactions, mergers and acquisitions, and regulatory compliance. Within her practice, Olivia counsels clients on navigating the complex web of federal and…

Olivia Vega provides strategic advice to global companies on a broad range of privacy, health care, and technology issues, including in technology transactions, mergers and acquisitions, and regulatory compliance. Within her practice, Olivia counsels clients on navigating the complex web of federal and state privacy and data security laws and regulations, including on topics such as HIPAA, California’s Confidentiality of Medical Information Act, and the California Consumer Privacy Act. In addition, Olivia maintains an active pro bono practice.

Photo of Jorge Ortiz Jorge Ortiz

Jorge Ortiz is an associate in the firm’s Washington, DC office and a member of the Data Privacy and Cybersecurity and the Technology and Communications Regulation Practice Groups.

Jorge advises clients on a broad range of privacy and cybersecurity issues, including topics related to…

Jorge Ortiz is an associate in the firm’s Washington, DC office and a member of the Data Privacy and Cybersecurity and the Technology and Communications Regulation Practice Groups.

Jorge advises clients on a broad range of privacy and cybersecurity issues, including topics related to privacy policies and compliance obligations under U.S. state privacy regulations like the California Consumer Privacy Act.